These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 34780081)
1. Changes in therapeutic options for hepatocellular carcinoma in Asia. Ogasawara S; Koroki K; Kanzaki H; Kobayashi K; Kiyono S; Nakamura M; Kanogawa N; Saito T; Kondo T; Nakagawa R; Nakamoto S; Muroyama R; Chiba T; Kato N Liver Int; 2022 Aug; 42(9):2055-2066. PubMed ID: 34780081 [TBL] [Abstract][Full Text] [Related]
2. Paradigm shift in the treatment options of hepatocellular carcinoma. Su TH; Hsu SJ; Kao JH Liver Int; 2022 Aug; 42(9):2067-2079. PubMed ID: 34515412 [TBL] [Abstract][Full Text] [Related]
3. Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020). Haber PK; Puigvehí M; Castet F; Lourdusamy V; Montal R; Tabrizian P; Buckstein M; Kim E; Villanueva A; Schwartz M; Llovet JM Gastroenterology; 2021 Sep; 161(3):879-898. PubMed ID: 34126063 [TBL] [Abstract][Full Text] [Related]
4. Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review. Cappuyns S; Corbett V; Yarchoan M; Finn RS; Llovet JM JAMA Oncol; 2024 Mar; 10(3):395-404. PubMed ID: 37535375 [TBL] [Abstract][Full Text] [Related]
5. First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination. Tella SH; Kommalapati A; Mahipal A; Jin Z Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740326 [TBL] [Abstract][Full Text] [Related]
6. Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life. Agirrezabal I; Brennan VK; Colaone F; Shergill S; Pereira H; Chatellier G; Vilgrain V Adv Ther; 2022 May; 39(5):2035-2051. PubMed ID: 35279814 [TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for the treatment of hepatocellular carcinoma. Ayoub WS; Jones PD; Yang JD; Martin P Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526 [TBL] [Abstract][Full Text] [Related]
12. Indonesian consensus on systemic therapies for hepatocellular carcinoma. Hasan I; Loho IM; Setiawan PB; Djumhana A; Purnomo HD; Siregar L; Gani RA; Sulaiman AS; Lesmana CRA Asia Pac J Clin Oncol; 2023 Feb; 19(1):263-274. PubMed ID: 35599455 [TBL] [Abstract][Full Text] [Related]
13. Current treatment options for hepatocellular carcinoma. Eugen K Klin Onkol; 2020; 33(Supplementum 3):20-25. PubMed ID: 33213161 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapies for hepatocellular carcinoma. Llovet JM; Castet F; Heikenwalder M; Maini MK; Mazzaferro V; Pinato DJ; Pikarsky E; Zhu AX; Finn RS Nat Rev Clin Oncol; 2022 Mar; 19(3):151-172. PubMed ID: 34764464 [TBL] [Abstract][Full Text] [Related]
15. Molecular therapies for HCC: Looking outside the box. Faivre S; Rimassa L; Finn RS J Hepatol; 2020 Feb; 72(2):342-352. PubMed ID: 31954496 [TBL] [Abstract][Full Text] [Related]
16. Systemic therapies for hepatocellular carcinoma: the present and the future. Celsa C; Giuffrida P; Stornello C; Grova M; Spatola F; Rizzo GEM; Busacca A; Cannella R; Battaglia S; Cammà C; Cabibbo G Recenti Prog Med; 2021 Feb; 112(2):110-116. PubMed ID: 33624623 [TBL] [Abstract][Full Text] [Related]
17. Systemic treatment for hepatocellular carcinoma. Ján T; Dáša S; Igor A; Jana V Klin Onkol; 2020; 33(5):356-361. PubMed ID: 33108880 [TBL] [Abstract][Full Text] [Related]
18. The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence. Cerreto M; Cardone F; Cerrito L; Stella L; Santopaolo F; Pallozzi M; Gasbarrini A; Ponziani FR Curr Oncol; 2023 Sep; 30(10):8774-8792. PubMed ID: 37887533 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for hepatocellular carcinoma: current status and future perspectives. Ikeda M; Morizane C; Ueno M; Okusaka T; Ishii H; Furuse J Jpn J Clin Oncol; 2018 Feb; 48(2):103-114. PubMed ID: 29253194 [TBL] [Abstract][Full Text] [Related]
20. Recent Progress in Systemic Therapy for Hepatocellular Cancer (HCC). Ghaziani TT; Dhanasekaran R Curr Treat Options Gastroenterol; 2021 Jun; 19(2):351-368. PubMed ID: 35530750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]